News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Dynavax (DVAX) In 2017: Hero Or Zero? 1/19/2017
Short-Seller Takes Another Shot at Tiny Massachusetts Biotech Cellceutix (CTIX) 1/19/2017
The Biotech That Performed the Best During the Obama Administration 1/19/2017
3 Medical Device Stocks Poised to Beat Earnings Estimates 1/18/2017
Georgia Bio Release: Life Sci Organization Highlights Deals Of The Year Spotlight Financings, Acquisitions And IPO 1/18/2017
Prima BioMed Release: CompanyTo Maintain NASDAQ Listing 1/18/2017
EnteroMedics (ETRM) Release: Company Announces Pricing Of $16.5 Million Underwritten Public Offering 1/18/2017
Why Celgene (CELG) Could be Considered Risky Because of Donald Trump 1/18/2017
How This Israeli Biotech Could be a Threat to Celgene (CELG) 1/18/2017
Valeant (VRX): Is Bausch & Lomb The Next To Fall? 1/18/2017
2017 Could be The Breakout Year for These 5 Biotechs 1/18/2017
Why Bristol-Myers Squibb (BMY) Could be a Takeover Target Soon 1/17/2017
Time to Get on the Train: 3 Biotechs That are About to Have Its Breakout Moment 1/17/2017
Google (GOOG)'s Verily Pumps 1.4 Billion Euros Into Ireland; Expansion to Create 400 New Jobs 1/17/2017
Why Vertex (VRTX) Stock Sank 42% In 2016 1/17/2017
How 4 Biotechs are Attempting to Change the Face of Healthcare 1/17/2017
Renovacare Release: 2017 Shareholder Update 1/17/2017
5 Trump-Proof Pharma Dividends Up To 5.3% 1/17/2017
Why Corbus (CRBP)' Stock Rocketed 412% Upwards in 2016 1/17/2017
A Look at Who's the Better Buy: Amgen (AMGN) or Celgene (CELG) 1/17/2017
A Look at Whether Johnson & Johnson (JNJ) Passes Warren Buffet's Acquisition Test 1/17/2017
Interpace Diagnostics Release: Company Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement 1/17/2017
Dechra Release: Company Trading Update 1/17/2017
OWC Pharmaceutical Research Corp. Release: Company Issues Annual Letter To Shareholders 1/17/2017
ProclaRx Release: Company Presented Technology And Business Updates At Medtech Showcase In San Francisco 1/17/2017
Trump's HHS Nominee and His Ties With Two Massachusetts Biotech Firms 1/16/2017
A Look at Whether Juno (JUNO) Can Recover After Losing More Than Half Its Value in 2016 1/16/2017
How This Reluctant Fitbit (FIT) Investor Almost Missed A $1.6 Billion Windfall 1/16/2017
7 Impressive Numbers for Intuitive Surgical (ISRG) 1/16/2017
Biotechs: What The 'Trump Dump' And CVS's EpiPen Move May Mean 1/16/2017
EXACT Sciences (EXAS) Release: Company Grants Inducement Restricted Stock Unit Awards To Recently Hired Employees 1/16/2017
Waters Corporation (WAT) Release: Company Issues Q4 2016 Financial Results Webcast Invitation 1/16/2017
Rigel (RIGL) Release: Pharma Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) 1/16/2017
Akers Biosciences: Biotech Announces Closing Of Public Offering 1/16/2017
Gilead (GILD): To Split or Not to Split... 1/13/2017
Trump Says Pharma Getting Away With Murder, Vows to Lower Drug Prices 1/13/2017
For A Tarnished Novavax (NVAX), This Could Be The Only Cure 1/13/2017
Taconic Biosciences Release: Company Expands European Immunodeficient Animal Production 1/13/2017
3 Little-Known Drugmakers That Deserve More Attention 1/13/2017
Mirati Therapeutics  (MRTX) Release: Pharma Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriter's Option To Purchase Additional Shares 1/12/2017
Neurotrope Release: Biotech Announces Reverse Split Of Common Stock In Preparation For NASDAQ Uplisting 1/12/2017
This Is the Smartest Move Valeant (VRX) Has Made In A Really Long Time 1/12/2017
Why Red-Hot Alexion (ALXN) Is Only Suitable For Risk Takers Now 1/12/2017
Biogen (BIIB) Release: Biotech's Spin-off Bioverativ Commences When-Issued Trading Of Common Stock 1/12/2017
Intrexon (XON) Release: Company Announces "When-Issued" Trading Of AquaBounty Technologies In Connection With Special Stock Dividend Of Shares 1/12/2017
Rosetta Genomics (ROSG) Release: Aegis Restates "Buy" Rating On Shares Of Rosetta Genomics 1/12/2017
Trump's Vow To Crack Down On Outsourcing Rattles Drug Makers With Factories In Asia 1/12/2017
JPM17: How Celgene (CELG) Wowed Yet Again 1/11/2017
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials 1/11/2017
How Gilead (GILD) Can Spend Its $32 Billion Stockpile to Reignite Investor Optimism 1/11/2017
Novanta (GSIG) Release: Company Increases Ownership In Laser Quantum To Over 75 Percent 1/11/2017
venBio Release: Company Sends Letter To Immunomedics (IMMU) Stockholders 1/11/2017
IDT Biologika Release:Life Science Company Establishes Animal Health Americas Business Unit 1/11/2017
CohBar Release: Company Announces Expiration Of Warrants And Reports Aggregate Proceeds From Warrant Exercises 1/11/2017
How Trump Can Propel Johnson & Johnson (JNJ) to New Heights 1/11/2017
Jaguar Animal Health, Inc. Release: Pharma Given Company Update By Aegis Capital Corp. 1/11/2017
EndoCeutics Release: Biopharma Secures $85 Million Credit Facility From CRG 1/11/2017
Millennium Health Release: Company Completes Corporate Transformation In 2016; Sets Stage For "Re-Launch" In 2017 1/11/2017
How Ariad (ARIA)'s Price Hikes Resulted in a $5 Billion Payday for Investors 1/10/2017
JPM17: Vertex (VRTX) Game Plan for Growth in 2017 1/10/2017
Immune Pharma Release: Company Will Request An Appeal To Regain Compliance With Nasdaq's Minimum Bid Price Rule 1/10/2017
Marapharm Ventures Inc. Release: Venture Company Invests In Veritas Pharma Inc 1/10/2017
BioLife Solutions, Inc. (BLFS.OB) Release: Company Amends Existing Credit Facility 1/10/2017
Varian Medical Systems (VAR) Release: Medical Device Company Announces Distribution Ratio And Record Date For Separation Of Imaging Components Business 1/10/2017
Perrigo (PRGO) Release: Company Updates Segment Reporting Structure 1/10/2017
Akers Biosciences Release: Company Announces Pricing Of Public Offering Of 1,667,000 Shares And 833,500 Warrants 1/10/2017
Medivir (MVRBF) Release: Notice Of Extraordinary General Meeting Of Company 1/10/2017
Otonomy (OTIC) Provides Corporate And Product Pipeline Update 1/9/2017
Adamas Pharma (ADMS) Outlines Key 2017 Priorities And Highlights 2016 Achievements 1/9/2017
Advaxis (ADXS) Provides 2017 Business Outlook 1/9/2017
Retrophin (RTRX) Provides Corporate Update And 2017 Preview 1/9/2017
Agios (AGIO) Announces Key Upcoming Milestones To Support Evolution To A Commercial Stage Biopharmaceutical Company In 2017 1/9/2017
Advanced Accelerator Applications CEO Provides Progress Report On Corporate Developments Of 2016; Asserts Confidence In Ability To Address FDA Comments On Lutathera NDA 1/9/2017
AMAG (AMAG) Provides Financial And Business Update 1/9/2017
Here's a Biotech IPO You Don’t Want To Miss 1/9/2017
What Happens If You Considered Gilead (GILD) A Startup 1/9/2017
DermTech Provides Business Update 1/9/2017
Week In Review: iCarbonX "Ecosystem" Invests $400 Million In Seven Companies 1/9/2017
Takeda (TKPYY) Notifies 4.48% Shareholding In TiGenix 1/9/2017
CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017 1/9/2017
PURE Bioscience (PURE) Well Positioned To Provide Solutions To 2017’s Key Food Safety Challenges 1/9/2017
ProNAi Therapeutics Relaunched As Sierra Oncology To Advance DDR-Based Cancer Drugs 1/9/2017
Medicure (MCU) Provides Apicore Secured Loan To Replace Knight Therapeutics Loan 1/9/2017
PTC Therapeutics (PTCT) Provides Corporate Update And Outlines 2017 Strategic Priorities To Maximize The Global Value Of Translarna And Advance Its Innovative Pipeline 1/9/2017
Audentes (BOLD) Provides Full Year 2017 Strategic Outlook And Financial Guidance 1/9/2017
Infinity Pharma (INFI) Provides 2017 Goals And Financial Guidance 1/9/2017
Syros Pharma Announces 2017 Strategic Priorities And Goals 1/9/2017
Vertex (VRTX) Provides Update On Business And Financial Performance And Research And Development Programs 1/9/2017
Arrowhead Pharma (ARWR) Provides Response To New Minority Shareholder Announcement 1/9/2017
Acerus (TRLPF) Announces Completion Of Loan Repayment 1/9/2017
The 4 Building Blocks That Pushed Exelixis (EXEL) Higher By 164% In 2016 1/6/2017
Sanofi (SNY) Investors Have Worst Day In Six Months 1/6/2017
Momenta (MNTA) Provides Year-End 2016 Corporate Update 1/6/2017
Dermira (DERM) Provides Corporate Update 1/6/2017
Why Alexion (ALXN) Is Overvalued 1/6/2017
STERIBITE Announces Close Of Private Placement Memorandum 1/6/2017
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of Common Stock 1/6/2017
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 1/6/2017
Crystal Ball Gazing: Biotech Predictions For 2017 1/6/2017
Concord Medical Services Holdings Limited (CCM) Announces Completion Of Private Offering By Its Subsidiary, Meizhong Jiahe Hospital Management Corp. Ltd 1/6/2017
3 Things Investors Might See From Illumina (ILMN) at J.P. Morgan Next Week 1/6/2017
Mirati Therapeutics  (MRTX) Announces Pricing Of Public Offering Of Common Stock 1/6/2017
Seventure Partners Life Sciences, Microbiome Investing Update For September - December 2016 1/6/2017
Juniper Pharma (JNP) Unveils Strategic And Product Development Objectives For 2017 1/6/2017
Illinois Biotechnology Industry Organization (iBIO) Changes Name To Reflect Its Mission And Role Of Member Companies 1/6/2017
OncoMed (OMED) Announces Year-End Cash Balance And 2017 Outlook 1/5/2017
Avadel Pharma (FLML) Provides 2017 Guidance And Business Update 1/5/2017
AOBiome Partners With iCarbonX And Secures $30 Million Investment For Drug Development 1/5/2017
TSO3 (TOS) Provides An Operational Update 1/5/2017
2 Biotech Giants That Will Survive The War Between Trump And The Democrats 1/5/2017
Orexigen (OREX) Highlights Key Business Priorities For 2017 1/5/2017
Rigel (RIGL) Provides Business Updates And Preliminary Data In IgA Nephropathy 1/5/2017
Imperial Innovations Release: Change Of Name To Touchstone Innovations Plc And Change Of Registered Office 1/5/2017
Tarveda Provides Year-End Update And Outlines Milestones For 2017 1/5/2017
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock 1/5/2017
Dextera Surgical Inc. (DXTR) Provides Corporate Update 1/5/2017
Bardy Diagnostics Announces Growth Capital Funding 1/5/2017
OptiBiotix Release: Microbiome Technology Powers The Healthy Weight Loss Company Expansion 1/5/2017
Bay Area's BridgeBio Pharma Comes Out of Stealth Mode 1/5/2017
Why This $1 Biotech Stock Is A Strong Buy For 2017 1/5/2017
Alzamend Neuro Launches Regulation A+ Tier II SEC Qualified Offering 1/4/2017
Cerus (CERS) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/4/2017
3 Quiet Biotechs Ready to Make Some Noise in 2017 1/4/2017
A Look Into Billionaire Dr. Phillip Frost's Risky Biotech Portfolio 1/4/2017
1 Bay Area and 1 Massachusetts Biotech That Made Investors Squeal With Glee Last Year 1/4/2017
Did Biogen (BIIB) Just Throw In The Towel To Celgene (CELG)? 1/4/2017
My Worst Predictions For Biotech In 2016 1/4/2017
CytoDyn (CYDY) Announces Investment Community Conference Call For January 5, 2017 1/4/2017
Lonza Group (LZAGY.PK) Concludes Divestment Of Peptides Business And Operations In Braine-l’Alleud, Belgium, To PolyPeptide 1/4/2017
Interpace Diagnostics Announces $4.2 Million Registered Direct Offering Of Common Stock 1/4/2017
Eiger Biopharma Completes $25 Million Debt Financing With Oxford Finance 1/4/2017
IDEXX Laboratories (IDXX) To Join S&P 500 Index 1/4/2017
3 Overlooked Drug Stocks To Watch Out For In 2017 1/4/2017
Oragenics (OGEN) Shareholder Update 1/4/2017
Clovis Oncology (CLVS) Announces Upsizing And Pricing Of Public Offering Of Common Stock 1/4/2017
Exelixis (EXEL) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/4/2017
Propanc Provides Shareholder Update And Forecast For 2017 1/4/2017
Cogmedix Announces Sales Growth And Major Business Systems Investment 1/4/2017
2 Struggling Biotechs And How To Play Them In 2017 1/3/2017
7 Biotech Stocks to Watch in 2017 1/3/2017
3 Of The Biggest Risks For Bristol-Myers Squibb (BMY) In 2017 1/3/2017
Portola (PTLA) To Webcast Corporate Update On January 10, 2017 1/3/2017
Conversion Right Triggered For LabCorp (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021 1/3/2017
Covalon Technologies Ltd. CEO Provides Update On Anticipated Fiscal 2017 Financial Growth 1/3/2017
Clovis Oncology (CLVS) Announces Proposed Offering Of Common Stock 1/3/2017
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 1/3/2017
Great Basin Scientific Stock Symbol Temporarily Changed To GBSND 12/30/2016
MMJ PhytoTech Release Of Restricted Securities From Escrow 12/30/2016
Why This Clinical Stage Biotech Should Be on Your Radar 12/30/2016
Looking Forward: This is Why 2017 Could Be a Breakout Year For Neos Therapeutics (NEOS) 12/30/2016
Stryker (SYK) Poised For Long-Term Gains 12/30/2016
Notice of Extraordinary General Meeting In BioInvent (BOVNF) 12/30/2016
Change in Number of Shares and Votes in Moberg Pharma AB (Formerly known as Moberg Derma) 12/30/2016
Share Conversion In RaySearch Laboratories 12/30/2016
Helix Biopharma (TSX:HBP) Announces Additional Private Placement Closing 12/30/2016
Change In The Number Of Shares And Votes In BioInvent (BOVNF) 12/30/2016
Dynatronics Corporation (DYNT) Announces Completion Of $975,000 Private Placement Led By Prettybrook Partners 12/30/2016
Golden Meditech To Sell Its Equity Interest In China Cord Blood For Cash Consideration Of RMB5.764 Billion 12/30/2016
3 Headwinds AbbVie (ABBV) Faces in 2017 12/29/2016
The 10 Largest Marijuana Companies 12/29/2016
EnteroMedics (ETRM) Announces Retirement of All Senior Convertible Notes 12/29/2016
Intrexon (XON) Announces A Special Stock Dividend Of Shares Of AquaBounty Technologies 12/29/2016
Hutchison China MediTech (Chi-Med): Blocklisting Six Monthly Return 12/29/2016
GeneNews (GEN.TO) Announces Closing Of Private Placement Of Convertible Debentures 12/29/2016
Interpace Diagnostics Announces 1-for-10 Reverse Split 12/29/2016
As R&D Returns Take A Hit, Some Pharmas Are Ramping Up Spending 12/29/2016
Biotech Pros Say The Sector Is Poised For A Comeback In 2017 12/29/2016
What Next for Aethlon Medical (AEMD) Stock After Achieving 1 Year Low? 12/29/2016
NeuroMetrix (NURO) Announces $7.0 Million Private Placement Of Preferred Stock And Warrants 12/29/2016
Investors, Put Your Emotions Aside: There is Hope for Valeant (VRX) in 2017 12/29/2016
Helix Biopharma (TSX:HBP) Closes Private Placement 12/29/2016
3 Worst Performing Pharma Stocks for 2016 12/29/2016
The GlaxoSmithKline (GSK)-Gilead (GILD) HIV Battle Could Be Epic 12/29/2016
2016 Was A Terrible Year For Biotech But The Tweets Were On Point 12/28/2016
Retractable Tech (RVP) Declares Dividends To Series I And II Class B Preferred Stock Shareholders 12/28/2016
A Turnaround: Regeneron (REGN) Eyes a Comeback in 2017 12/28/2016
The Last Week Of 2016 Could Be Big For These 9 Biotech Catalysts 12/28/2016
What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016 12/27/2016
These 3 Biotech Stocks Are Better Buys Than Gilead (GILD) 12/27/2016
Will 2017 Be Gilead (GILD)'s Worst Year Yet? 12/27/2016
The 3 Biggest Risks for Pfizer (PFE) in 2017 12/27/2016
Principia Invests 4 Million Euros In AnaBios Corporation 12/27/2016
EnteroMedics (ETRM) Announces 1-for-70 Reverse Stock Split 12/27/2016
TiGenix: Notice In Relation To The Convertible Bonds Due 2018 12/27/2016
Entest Biomedical, Inc. Chairman David Koos Discusses Zander Therapeutics Subsidiary And Future Plans For The Company Moving Into 2017 12/27/2016
TSO3 (TOS) Secures Access To Non-Dilutive Growth Capital Through Receivables Factoring 12/27/2016
BioAmber Announces $7 Million Underwritten Offering Of Common Stock And Concurrent $8.9 Million Registered Direct Offering Of Warrants 12/27/2016
Sinovac Biotech Ltd. (SVA) Responds To Recent Report 12/27/2016
OvaScience (OVAS) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/27/2016
InMed Provides 2016 Year End Update 12/27/2016
Biogen (BIIB) Announces Effectiveness Of Bioverativ Form 10 Registration Statement 12/27/2016
DiaMedica Announces Name Change To DiaMedica Therapeutics Inc. 12/27/2016
Nutra Pharma Corp. (NPHC) Letter To Shareholders 12/27/2016
Rasna Therapeutics (ATVM) Closes Private Placement Of $2 Million 12/27/2016
Fuse Medical Announces $720,000 Capital Investment and New Leadership 12/27/2016
Blake Insomnia Therapeutics (BKIT) Wants To Awaken A Billion Dollar Industry 12/22/2016
NeuroDerm (NDRM) Announces Closing Of Public Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 12/22/2016
Antibe Therapeutics (ATE.V) Completes Final Closing Of Private Placement Bringing Total Proceeds To $2.7 Million 12/22/2016
NeoGenomics (NGNM.OB) Closes $150 Million Senior Credit Facility 12/22/2016
Kane Biotech Inc. (KNE) Announces Issuance Of Common Shares In Payment Of Outstanding Interest 12/22/2016



//-->